Biochemical and Biophysical Research Communications
Volume 54, Issue 4, 15 October 1973, Pages 1362-1369
Modulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity with cAMP and with protein fractions of rat liver cytosol
References (13)
- et al.
J. Biol. Chem
(1966) - et al.
J. Biol. Chem
(1971) - et al.
J. Biol. Chem
(1959) - et al.
Biochem. Biophys. Res. Commun
(1973) - et al.
J. Biol. Chem
(1972) - et al.
Arch. Biochem. Biophys
(1972)
There are more references available in the full text version of this article.
Cited by (229)
Biochemical purification uncovers mammalian sterile 3 (MST3) as a new protein kinase for multifunctional protein kinases AMPK and SIK3
2022, Journal of Biological ChemistryMyeloid deletion and therapeutic activation of AMPK do not alter atherosclerosis in male or female mice
2020, Journal of Lipid ResearchRegulation of podocytes function by AMP-activated protein kinase
2020, Archives of Biochemistry and BiophysicsCitation Excerpt :Extensive research has been conducted on the role and function of AMP-activated protein kinase (AMPK) since its discovery in 1973. In parallel studies, Carlson & Kim and Beg et al. described AMPK as different soluble protein factors that, on one hand, inactivated acetyl-CoA carboxylase, which was proposed to be due to a direct phosphorylation [1], and on the other hand, inhibited 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase [2]. Finally, in 1987, it was shown that the activities of these two enzymes were regulated by the same protein, which was called AMPK [3].
AMPK Alchemy: Therapeutic Potentials in Allergy, Aging, and Cancer
2024, Biomolecules and TherapeuticsTissue-Specific Regulation of
2023, SSRN
- ∗
Research supported by grants from the N.H.L.I. (HL-0419-15); the American Heart Association (70-680); and the Indiana Heart Association.
Copyright © 1973 Published by Elsevier Inc.